WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2006085092) METHODS AND USES OF ANTIBODIES IN THE PURIFICATION OF INTERFERON
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2006/085092    International Application No.:    PCT/GB2006/000471
Publication Date: 17.08.2006 International Filing Date: 13.02.2006
IPC:
C07K 16/24 (2006.01), C07K 14/56 (2006.01), A61K 38/21 (2006.01)
Applicants: VIRANATIVE AB [SE/SE]; Tvistevagen, Box 7979, S-907 Umea (SE) (For All Designated States Except US).
ROBERTSON, Colin [GB/GB]; (GB) (For US Only).
SMITH, Julie [GB/GB]; (GB) (For US Only).
LUNDGREN, Erik [SE/SE]; (SE) (For US Only).
LUNDBERG, Sven [SE/SE]; (SE) (For US Only)
Inventors: ROBERTSON, Colin; (GB).
SMITH, Julie; (GB).
LUNDGREN, Erik; (SE).
LUNDBERG, Sven; (SE)
Agent: MURGITROYD & COMPANY; Scotland House, 165-169 Scotland Street, Glasgow G5 8PL (GB)
Priority Data:
0502991.3 12.02.2005 GB
60/771,622 09.02.2006 US
Title (EN) METHODS AND USES OF ANTIBODIES IN THE PURIFICATION OF INTERFERON
(FR) PROCEDE ET UTILISATIONS D'ANTICORPS DANS LA PURIFICATION D'INTERFERON
Abstract: front page image
(EN)The present invention provides improved methods and uses of an immunoglobulin in the purification of an interferon composition. The methods of the invention provide for the use of a monoclonal antibody in the purification of an interferon composition comprising a plurality of interferon alpha subtypes . The use of the monoclonal antibody provides for the production of an interferon composition with a consistent proportion of interferon subtypes, providing a resulting improvement in simplicity of production of the resulting interferon composition.
(FR)L'invention porte sur des procédés et des utilisations améliorés d'une immunoglobuline dans la purification d'une composition d'interféron. Ces procédés permettent l'utilisation d'un anticorps monoclonal dans la purification d'une composition d'interféron contenant une pluralité de sous-types d'interféron alpha. L'utilisation d'un anticorps monoclonal permet la fabrication d'une composition d'interféron avec une proportion conforme de sous-types d'interféron, ce qui permet d'améliorer la simplicité de fabrication de la composition d'interféron obtenue.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)